Skip to content
Search
About WifOR
Health
Burden of Disease
Health Economy Reporting
Health ROI Assessor
Social Impact
Impact Analysis
Products
Economic and R&D Footprint
Impact Accounting
Scope 3 Assessment
WISIT – the WifOR Institute Sustainability Impact Tool
Data packages
GHG Emission Factors
Spend-based Multipliers for Sustainability Analysis
Value Factors
Ressources
Benchmarks
Value Factors
Labor Market
Big Data Skills Analysis
Diversity, Equity & Inclusion
Diversity study
Employer Attractiveness Analysis
Workforce Forecasts
Publications
Newsroom
Career
DE
EN
Contact
Latest publications
Journal publication
Uwe Holzwarth, Roberta Cirillo, Margarida Goulart, Dr. Diego Hernandez, Dr. Platon Peristeris, Andreas Poschenreider, Panagiota Papaioannou, Panos Kanavos, Christian la Fougère, Leonhard Schaetz
06/2026
Estimation of Future Patient Populations Eligible for Radioligand Therapies in the EU and the UK: A Modelling Study
Method paper
Prof. Dr. Dennis A. Ostwald, Dr. Malina Müller, Dr. Sandra Zimmermann, Ceyda Ural, Hatice Beton
12/2025
Healthy Returns: A Catalyst for Economic Growth and Resilience
Study
Adnan Atitallah, Hamza Liaqat, Dr. Rita Maghularia, Davide Lovera, Dr. Eva Levi, Dr. Malina Müller
07/2026
Socioeconomic Burden and Annual Social Impact of Roche Treatments for HER2+ Breast Cancer, Multiple Sclerosis and Retinal Disease
Library
Research area
Career
Health
Labor Market
Newsletter
Sustainability
Publication type
Conference poster
Journal publication
Method paper
Scientific article
Study
Conference poster
2019
The Social Impact of Erenumab in Prophylactic Treatment of Patients with Migraine in Germany: A Macroeconomic Open-Cohort Approach
Ahmed Seddik, Claudio Schneider, Jennifer Branner, Prof. Dr. Dennis Ostwald, Dr. Jasper Huels
Conference poster
2019
German Cost Analysis of Triplet Regimens for Relapsed or Refractory Multiple Myeloma Patients
Dr. Mathias Kappel, Dr. Arpit Misra, Edin Basic, Janine Pöpper, Boris A. Ratsch, Prof. Dr. Dennis Ostwald
Journal publication
2019
The societal impact of Erenumab in prophylactic treatment of patients with migraine in Germany: a macroeconomic open-cohort approach
Ahmed Seddik, Ahmed Seddik, Claudio Schneider, In collaboration with Dr. Jasper Huels (Novartis), Jennifer Branner, Prof. Dr. Dennis Ostwald
Journal publication
2019
German cost analysis of triplet regimens for relapsed or refractory multiple myeloma patients
Dr. Arpit Misra, Dr. Mathias Kappel, In collaboration with Boris A. Ratsch (Takeda), In collaboration with Edin Basic (Takeda), Janine Pöpper, Prof. Dr. Dennis Ostwald
Study
2019
The Social Impact of Novartis medicines: Two Case Studies from South Africa and Kenya
Ahmed Seddik, Ahmed Seddik, Jennifer Branner, Prof. Dr. Dennis Ostwald, Remon Helmy
Study
2019
The Environmental Impact of Novartis Along Global Supply Chains
Dr. Marcus Cramer, Dr. Richard Scholz, In collaboration with Sonja Haut (Novartis), Natalia Benke, Nora Albu, Prof. Dr. Dennis Ostwald
‹
1
…
16
17
18
19
20
21
›
Interested in our newsletter?
Register
